The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy

Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer

(2015) Geetha Srikrishna et al.   NEOPLASIA

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

High-mobility group box 1 and cancer

(2010) Daolin Tang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation

(2010) Sarah D. Lamore et al.   CURRENT DRUG METABOLISM

Anticancer effects of CAMEL peptide

(2010) Ryszard Smolarczyk et al.   LABORATORY INVESTIGATION

The translocation of HMGB1 during cell activation and cell death

(2009) Julie Gauley et al.   AUTOIMMUNITY

Targeting HMGB1 in inflammation

(2009) Huan Yang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Tumors Sound the Alarmin(s)

(2008) S. B. Coffelt et al.   CANCER RESEARCH

HMGB1: a two-headed signal regulating tumor progression and immunity

(2008) Lara Campana et al.   CURRENT OPINION IN IMMUNOLOGY

Tumor-host interactions: the role of inflammation

(2008) Marie-Aude Bitoux et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Unknown

(2008) John Klune et al.   MOLECULAR MEDICINE